ArticleAACE endocrinology and diabetes
Artifactual Hypoglycemia Masquerading as a Medical Emergency: A Diagnostic Pitfall of High-Dose Vitamin C.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Severe hypoglycemia prompts emergent intervention, yet not all low glucose readings reflect true hypoglycemia. We present a striking case of extreme artifactual hypoglycemia due to high-dose vitamin C therapy, highlighting the diagnostic challenges and management implications. Case Report: A 76-year-old man with metastatic prostate cancer, receiving high-dose vitamin C as part of alternative therapy, presented with worsening malaise, oliguria, and edema. On presentation, despite critically low blood glucose (BG) reading (<20 mg/dL) on both point-of-care glucometer and laboratory testing, the patient remained asymptomatic. Repeated dextrose infusions failed to increase the recorded BG levels, contradicting the expected response in true hypoglycemia. Dialysis, rather than dextrose, ultimately corrected his BG readings. Additionally, his liver enzymes, initially undetectable on presentation, became measurable as dialysis progressed. Further investigation identified markedly elevated vitamin C levels as the interfering substance, affecting both standard glucose and liver enzyme assays, leading to pseudo-hypoglycemia. Discussion: This case highlights the impact of high-dose vitamin C on glucose oxidase-based assays, causing pseudohypoglycemia and potentially triggering inappropriate clinical interventions. Also, over-reliance on laboratory values without clinical correlation can be costly and problematic particularly in critically ill patients, emphasizing the need for contextual interpretation of biochemical data. Alternative glucose measurement methods, such as hexokinase assays, may be required in suspected cases. Conclusion: Clinicians should suspect pseudohypoglycemia when glucose readings are critically low but the patient lacks corresponding symptoms, especially in patients pursuing alternative medicine. Whipple's Triad remains vital in differentiating true hypoglycemia from laboratory artifact, preventing unnecessary escalation of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.